The present invention relates to spiro compounds containing electron-conducting groups and to electronic devices, in particular organic electroluminescent devices, comprising these compounds.

The present invention relates to spiro compounds containing electron-conducting groups and to electronic devices, in particular organic electroluminescent devices, comprising these compounds.

The present invention provides a class of pyrimidinedione cyclohexenyl compounds and methods of using these compounds as glucocorticoid receptor modulators.

An organic electroluminescence device having a cathode; an anode; and an emitting layer disposed between the cathode, wherein a first layer in an electron-transporting zone disposed between the emitting layer and the cathode contains a first compound and a second compound, the electron mobility μ.sub.1 of the first compound is 1.0×10.sup.−5 cm.sup.2/Vs or lower, and the second compound is one or more selected from the group consisting of compounds represented by each of the following formulas (11), (12), and (13), provided that the first compound and the second compound are different compounds.

##STR00001##

An organic electroluminescence device having a cathode; an anode; and an emitting layer disposed between the cathode, wherein a first layer in an electron-transporting zone disposed between the emitting layer and the cathode contains a first compound and a second compound, the electron mobility μ.sub.1 of the first compound is 1.0×10.sup.−5 cm.sup.2/Vs or lower, and the second compound is one or more selected from the group consisting of compounds represented by each of the following formulas (11), (12), and (13), provided that the first compound and the second compound are different compounds.

##STR00001##

A heterocyclic compound and an organic light-emitting device including the same are provided. The heterocyclic compound is represented by Formula 1: ##STR00001## Details of R1, R2, R3, X1, L1, and a1 and b1 are provided in the disclosure.

A heterocyclic compound and an organic light-emitting device including the same are provided. The heterocyclic compound is represented by Formula 1: ##STR00001## Details of R1, R2, R3, X1, L1, and a1 and b1 are provided in the disclosure.

A compound for an organic optoelectronic device, a composition for an organic optoelectronic device including the same, an organic optoelectronic device, and a display device, the compound being represented by Chemical Formula 1:

##STR00001##

A compound for an organic optoelectronic device, a composition for an organic optoelectronic device including the same, an organic optoelectronic device, and a display device, the compound being represented by Chemical Formula 1:

##STR00001##

The disclosure relates to compounds of formula I, which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases. ##STR00001##